查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585757

骨移植市場：按類型、應用和最終用戶分類 - 全球預測 2025-2030

Bone Allografts Market by Type (Corticocancellous Bone Allografts, Massive Structural Bone Allografts, Osteoinductive Bone Allografts), Application (Dental, Reconstruction & Traumatology, Spine), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年骨移植市場估值為50億美元，預計2024年將達54.1億美元，複合年成長率為8.63%，預計2030年將達到89.4億美元。

骨移植涉及將骨組織從供體移植到受體。這種生物材料在整形外科手術中非常重要，可提供結構支撐並促進自然骨骼生長。骨移植的需求涉及範圍廣泛，包括骨折、脊椎融合手術、重組手術和牙科手術，在這些情況下，由於供體部位發病率或可用性有限等因素，自體移植可能不可行。最終用途主要是在醫院、整形外科診所和牙科診所。骨移植市場的關鍵成長要素包括全球人口老化、骨質疏鬆症和關節炎盛行率上升以及對微創整形外科手術的需求不斷增加。此外，技術進步和生物相容性的提高提高了骨移植的有效性，促進了其更廣泛的採用。然而，疾病傳播風險、可能的免疫反應排斥以及嚴格的監管核准等挑戰正在阻礙市場成長。醫療基礎設施不斷擴大的新興市場以及脫礦骨基質和莫氏鬆質骨移植物等創新加工技術的開拓，以增強移植物的整合和性能，都存在機會。該調查將重點放在模仿同種異體移植物特性的合成替代品的研究，並探索與組織庫的合作夥伴關係，以簡化骨移植物的採購和加工。增強移植物功能的生物工程技術，例如整合生長因子和幹細胞，是重要的創新領域。儘管存在合成替代品和自體移植的競爭，但由於組織工程的進步以及安全性和有效性標準提高所帶來的廣泛接受，該市場本質上具有彈性，並且具有成長潛力。因此，企業應注重技術創新和策略聯盟，以保持競爭力並有效應對不斷成長的需求。

主要市場統計
基準年[2023] 50億美元
預測年份 [2024] 54.1億美元
預測年份 [2030] 89.4億美元
複合年成長率（%） 8.63%

市場動態：快速發展的骨移植市場的關鍵市場洞察

供需的動態交互作用正在改變骨移植市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 骨質疏鬆症和牙科疾病的盛行率增加
    • 整形外科手術數量增加
    • 肌肉骨骼疾病 (MSD) 增加
  • 市場限制因素
    • 圍繞骨移植治療費用高的擔憂
  • 市場機會
    • 生物相容性合成骨移植簡介
    • 醫療設備領域新技術進展
  • 市場挑戰
    • 骨移植手術相關的併發症和倫理問題

波特五力：駕馭骨移植市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解骨移植市場的外部影響

外部宏觀環境因素在塑造骨移植市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解骨移植市場的競爭格局

對骨移植市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位基質骨移植市場供應商績效評估

FPNV定位矩陣是評估骨移植市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了骨移植市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，骨移植市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 骨質疏鬆症和牙科疾病增加
      • 整形外科手術增加
      • 肌肉骨骼疾病 (MSD) 病例增加
    • 抑制因素
      • 對昂貴的骨移植治療的擔憂
    • 機會
      • 生物相容性合成骨移植簡介
      • 醫療設備領域新技術進展
    • 任務
      • 骨移植手術相關的併發症和倫理問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章骨移植市場：依類型

  • 皮質海綿狀肝血管瘤植骨
  • 大型結構性骨移植
  • 骨誘導骨移植

第7章骨移植市場：依應用分類

  • 牙科
  • 重組與創傷學
  • 脊椎
  • 運動外科

第8章骨移植市場：依最終用戶分類

  • 門診手術中心
  • 醫院和專科診所

第9章美洲骨移植市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太骨移植市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的骨移植市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AlloSource
  • Baxter International Inc.
  • Biomatlante
  • Biowy Corporation
  • botiss biomaterials GmbH
  • Geistlich Pharma AG
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Lynch Biologics, LLC
  • Medical Device Business Services, Inc.
  • Medtronic PLC
  • Nobel Biocare Services AG
  • NuVasive, Inc.
  • Orthofix US LLC
  • PuraGraft
  • Smith & Nephew PLC
  • Stryker Corporation
  • Surgical Esthetics Biomedical
  • SURGILOGIX
  • TBF Tissue Engineering
  • Wright Medical Group NV
  • Xtant Medical
  • Zimmer Biomet
Product Code: MRR-F927BA462598

The Bone Allografts Market was valued at USD 5.00 billion in 2023, expected to reach USD 5.41 billion in 2024, and is projected to grow at a CAGR of 8.63%, to USD 8.94 billion by 2030.

Bone allografts involve transplanting bone tissue from a donor to a recipient, typically to repair or replace bone following injury or disease. This biological material is critical in orthopedic surgeries, providing structural support and promoting natural bone growth. The necessity of bone allografts is underscored by their role in addressing a wide array of conditions including fractures, spinal fusions, reconstructive surgeries, and dental procedures, where autografts may not be viable due to factors such as donor site morbidity or limited availability. The end-use scope revolves around hospitals, orthopedic clinics, and dental practices. Key growth factors for the bone allograft market include an aging global population, rising incidence of osteoporosis and arthritis, and increased demand for minimally invasive orthopedic procedures. Furthermore, technological advancements and improved biocompatibility in allograft processing enhance their efficacy, encouraging wider adoption. However, challenges such as the risk of disease transmission, potential for immune response rejection, and stringent regulatory approvals hamper market growth. Opportunities lie in emerging markets where healthcare infrastructure is expanding, as well as in the development of innovative processing techniques such as demineralized bone matrix and morselized cancellous allografts to enhance graft integration and performance. Recommendations would focus on investing in research for synthetic alternatives that mimic allograft properties and exploring partnerships with tissue banks to streamline the procurement and processing of bone allografts. An area for significant innovation is bioengineering techniques that enhance graft functionality, such as incorporating growth factors or stem cells. The market is inherently resilient, although competitive with synthetic alternatives and autografts, offering potential for growth driven by advancements in tissue engineering and a broader acceptance stemming from improved safety and efficacy standards. Consequently, businesses should focus on innovation and strategic collaborations to maintain competitiveness and meet rising demand effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 5.00 billion
Estimated Year [2024] USD 5.41 billion
Forecast Year [2030] USD 8.94 billion
CAGR (%) 8.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bone Allografts Market

The Bone Allografts Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of osteoporosis and dental problems
    • Rising number of orthopedic surgeries
    • Increase in cases of Musculoskeletal disorders (MSD)
  • Market Restraints
    • Concern associated with expensive treatments of bone allografts
  • Market Opportunities
    • Introduction of biocompatible synthetic bone allografts
    • Emerging technological advancement in medical device sector
  • Market Challenges
    • Associated complications and ethical issues of bone grafting surgeries

Porter's Five Forces: A Strategic Tool for Navigating the Bone Allografts Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bone Allografts Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bone Allografts Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bone Allografts Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bone Allografts Market

A detailed market share analysis in the Bone Allografts Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bone Allografts Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bone Allografts Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bone Allografts Market

A strategic analysis of the Bone Allografts Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Allografts Market, highlighting leading vendors and their innovative profiles. These include AlloSource, Baxter International Inc., Biomatlante, Biowy Corporation, botiss biomaterials GmbH, Geistlich Pharma AG, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Lynch Biologics, LLC, Medical Device Business Services, Inc., Medtronic PLC, Nobel Biocare Services AG, NuVasive, Inc., Orthofix US LLC, PuraGraft, Smith & Nephew PLC, Stryker Corporation, Surgical Esthetics Biomedical, SURGILOGIX, TBF Tissue Engineering, Wright Medical Group N.V., Xtant Medical, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Bone Allografts Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Corticocancellous Bone Allografts, Massive Structural Bone Allografts, and Osteoinductive Bone Allografts.
  • Based on Application, market is studied across Dental, Reconstruction & Traumatology, Spine, and Sports Surgery.
  • Based on End-User, market is studied across Ambulatory Surgical Centers and Hospital & Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of osteoporosis and dental problems
      • 5.1.1.2. Rising number of orthopedic surgeries
      • 5.1.1.3. Increase in cases of Musculoskeletal disorders (MSD)
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with expensive treatments of bone allografts
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of biocompatible synthetic bone allografts
      • 5.1.3.2. Emerging technological advancement in medical device sector
    • 5.1.4. Challenges
      • 5.1.4.1. Associated complications and ethical issues of bone grafting surgeries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bone Allografts Market, by Type

  • 6.1. Introduction
  • 6.2. Corticocancellous Bone Allografts
  • 6.3. Massive Structural Bone Allografts
  • 6.4. Osteoinductive Bone Allografts

7. Bone Allografts Market, by Application

  • 7.1. Introduction
  • 7.2. Dental
  • 7.3. Reconstruction & Traumatology
  • 7.4. Spine
  • 7.5. Sports Surgery

8. Bone Allografts Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospital & Specialty Clinics

9. Americas Bone Allografts Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bone Allografts Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bone Allografts Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AlloSource
  • 2. Baxter International Inc.
  • 3. Biomatlante
  • 4. Biowy Corporation
  • 5. botiss biomaterials GmbH
  • 6. Geistlich Pharma AG
  • 7. Integra LifeSciences Holdings Corporation
  • 8. Johnson & Johnson Services, Inc.
  • 9. Lynch Biologics, LLC
  • 10. Medical Device Business Services, Inc.
  • 11. Medtronic PLC
  • 12. Nobel Biocare Services AG
  • 13. NuVasive, Inc.
  • 14. Orthofix US LLC
  • 15. PuraGraft
  • 16. Smith & Nephew PLC
  • 17. Stryker Corporation
  • 18. Surgical Esthetics Biomedical
  • 19. SURGILOGIX
  • 20. TBF Tissue Engineering
  • 21. Wright Medical Group N.V.
  • 22. Xtant Medical
  • 23. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. BONE ALLOGRAFTS MARKET RESEARCH PROCESS
  • FIGURE 2. BONE ALLOGRAFTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BONE ALLOGRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BONE ALLOGRAFTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BONE ALLOGRAFTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BONE ALLOGRAFTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BONE ALLOGRAFTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BONE ALLOGRAFTS MARKET DYNAMICS
  • TABLE 7. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY CORTICOCANCELLOUS BONE ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY MASSIVE STRUCTURAL BONE ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY OSTEOINDUCTIVE BONE ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY RECONSTRUCTION & TRAUMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY SPINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY SPORTS SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BONE ALLOGRAFTS MARKET SIZE, BY HOSPITAL & SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BONE ALLOGRAFTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BONE ALLOGRAFTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BONE ALLOGRAFTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM BONE ALLOGRAFTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. BONE ALLOGRAFTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. BONE ALLOGRAFTS MARKET, FPNV POSITIONING MATRIX, 2023